Akebia Therapeutics, Inc.
Ticker: 1517022
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
36.90
-24.9%-37.2%
Expenditure
48.37
-12.8%-11.0%
Net Profit
-14.35
-61.1%-2757.4%
OPM %
-31.06%
-18.18pp-38.63pp
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingAKBA
20266Nov
Board Meeting
Nicholas Grund, Senior Vice President and Chief Commercial O…
SEC Filing ↗ Board MeetingAKBA
202617Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, appr…
SEC Filing ↗